SAVE LIVES. END THE SUFFERING.
Accelerating Life-Saving Breakthroughs Through America's First Biotech Freedom City
Singapore. Dubai. Now, Neovia.
Where life-changing cures happen 10x faster.
FDA Fast-Track Access
Immediate Benefits
Federal Status
Save Lives FAST
The Race Against Time
Every day, 150,000 people die from diseases we could cure faster.
Current timelines: 8-15 years. Neovia timeline: 18 months.
The cost of delay isn't just money—it's lives.
THE RISING GLOBAL ALLIANCE TO CURE THE INCURABLE
The Heroes We've Met Working Toward Ending Fatal Diseases And Aging
From world-renowned scientists and biotech CEOs to investors, policy leaders, and everyday visionaries—over 2,000+ people from all walks are uniting behind the movement to accelerate life-saving innovation.
Elizabeth Parrish
Founder and CEO of BioViva
Dr. Bill Andrews
CEO of Sierra Sciences
Aubrey de Grey
Chief Science Officer of LEV Foundation
Dr. Greg Fahy
Chief Scientific Officer • Co-Founder of Intervene Immune
José Cordeiro
Engineer, Futurist, & Author
William Faloon
Co-Founder of Life Extension Foundation
Kai Micah Mills
Founder of Cryopets, CryoDAO • HydraDAO – Thiel Fellow
Yuta Lee
Founder and CEO of Accelerated Biosciences Corp.
Ivan Morgunov
Founder and CEO of Unlimited Bio
Dr. Jean Hebert
Program Manager at ARPA-H • Author of Replacing Aging
Dr. David Wood
Executive Director of the LEV Foundation • Futurist Author & Symbian Co‑Founder
Bernard Siegel
Executive Director of Regenerative Medicine Foundation; Founder & Chair of World Stem Cell Summit
Dr. Melissa Peterson
Founder & CEO of Human Longevity Institute; Co‑Founder & CEO of Peptide University
Kenneth Scott
Biohacker, Biotech Investor & Longevity Advocate
Dr. Ines O'Donovan
Editor‑in‑Chief & Founder of Jeunessima
Gennedy Stolyarov
Chairman, U.S. Transhumanist Party • Author of Death Is Wrong
Johnny Adams
CEO & Executive Director of Aging Intervention Foundation
Jim Marchant
Congressional Candidate
James Strole
Executive Director and Co-Founder of Coalition for Radical Life Extension
Sagar Chopra
Co-Founder Empower Sleep
Neal VanDeRee
Officiator, Church of Perpetual Life
Dr. Peter Muran
Founder & Medical Director of Longevity Healthcare
Jean Weidmann
Partnerships & Innovation Manager, Coalition for Radical Life Extension
+ Thousands More
The Crisis Holding Back Breakthrough Medicine
Millions are dying, trillions are wasted, and global economies are at risk—not because we lack the cures, but because outdated systems are blocking them.
Millions Worldwide Are Dying from Disease & Illness that Can Be Cured
Breakthroughs Are Being Blocked by Outdated Regulatory Environments
Trillions in Healthcare Costs Preventable
Aging Populations Threaten Global Economies
A Biotech Renaissance Is Imminent
The Window to Lead Is Closing
The 3 Bottlenecks Neovia Breaks
To unleash the future of health, we must remove the bottlenecks that are stopping progress cold.
01
Over-Regulation Is Killing Innovation
Life-saving therapies are trapped in 10-year pipelines.
Neovia unlocks them with Freedom Zones—regulatory sandboxes where science moves at the speed of discovery, not bureaucracy.
From 15 years to 2. That’s how we save lives faster.
Freedom Zone → Rapid approvals → More cures → More lives saved
02
Funding Is Bottlenecked by Bureaucracy
When progress is slow, capital stays on the sidelines.
Neovia changes the equation:
Each dollar becomes 10x more efficient
Investors see fast ROI
Billions in biotech funding flood in
This is the dam-break moment for capital into cures
Faster market access → Higher ROI → More capital → More cures
03
Public Support Fades Without Results
People don’t rally behind theories. They rally behind visible, rapid breakthroughs.
Neovia delivers results in real time—turning scientists into heroes and igniting global demand for longevity.
When families see lives saved, the world unites.
Rapid results → Public demand → Funding surge → Cures at scale
Neovia clears the path for rapid cures, serious investment, and unstoppable public momentum.
This is how we end unnecessary suffering—at scale.
Meet the Pioneers Powering the Movement
Voices of the Movement
Hear directly from the scientists, founders, investors, and pioneers leading the charge to cure disease, extend life, and transform the future of healthcare.
Mark Hamilton: The Missing Puzzle Piece to Curing Aging and Death
José Cordeiro: The Death of Death
Dr. Bill Andrews: Pioneer of Telomere Research & Anti-Aging Science
Liz Parrish: One Woman Redefined the Frontiers of Rejuvenation
Dr. Aubrey De Grey: Reaching Longevity Escape Velocity
Dr. Greg Fahy: Turning Back Time Through Thymus Rejuvenation & Immune Renewal
Bernard Siegel; From Courtroom to Congress—Accelerating Cures with Policy & People
Bill Faloon: Fighting Decline with Science, Supplements, and Contrarian Thinking
Ivan Murgunov: Multidirectional Rejuvenation Could Add 20 Years to Life
Dr. Jean Hebert: From Repairing Brain Damage to Tissue Replacement
Dr. Matt Kaeberlein: Science That Could Save Your Life (And Your Dog's)
Dr. David Wood: Outrun Aging Before It Takes More Lives
James Strole: Fighting Aging, Healing Communities, and Saving Generations
Neal VanDeRee
Melissa Peterson
Gennady Stolyarov II
Jim Marchant
Josephine Musco
Kai Micah
Sagar Chopra
Clinton Hughes
Dr Ines
Dr Peter Muran
Jason Steinbrunn
Why Neovia?
Speed To Saving Lives
8 Years → 18 Months
Fast-track pathways that get life-saving therapies to patients faster.
World-Class Innovation Hub
Leading Scientists & Companies United
Top researchers, breakthrough companies, and cutting-edge infrastructure in one place.
Biotech Renaissance
America's Innovation Revival
Restoring American leadership in breakthrough medical discoveries.
Global Magnet for Talent
The World's Best Come Here
Attracting top scientists, companies, and capital from around the globe to advance human health.
THE MISSION
Ending Suffering.
Extending Life.
Advancing Humanity.
The diseases that have plagued humanity for centuries—cancer, heart disease, Alzheimer's, depression—don't have to be death sentences anymore.
In Neovia, visionary scientists and breakthrough thinkers aren't just developing treatments. We're engineering cures.
By targeting the root causes of aging and age-related diseases, families will never have to watch loved ones fade away from conditions we have the science to defeat.
The Timeline:
Today: Breakthrough therapies trapped in decade-long approval processes
Neovia Launch: Accelerated pathways unlock life-saving treatments in months, not years.
In 10 Years: Aging becomes optional, suffering becomes preventable, and families are no longer torn apart by disease.
Committed Founding Partners
FOUNDER & CEO OF BIOVIVA SCIENCES
Liz Parrish
Liz Parrish is a respected voice in gene therapy and the founder of BioViva Sciences, a company dedicated to advancing regenerative medical technologies. Her focus is on accelerating scientific pathways that address age-related diseases through targeted cellular interventions.
As an early supporter of Neovia, her leadership reinforces the city’s commitment to practical, patient-centered innovation.
Key Highlights
Founder of one of the world’s most recognized gene therapy startups
Advocate for medical freedom and accelerated biotech access
Signed Neovia’s LOI to support deregulated therapeutic development
FOUNDER & CEO OF SIERRA SCIENCES
Dr. Bill Andrews
Dr. Andrews is a renowned molecular biologist with over three decades of experience in genetic research and therapeutic development.
He is the founder of Sierra Sciences, a biotech company at the forefront of exploring ways to address cellular aging mechanisms. With dozens of patents and a career rooted in scientific rigor, Dr. Andrews brings world-class credibility to Neovia’s biotech vision.
Key Highlights
Holds over 60 patents in molecular biology and telomere research
Former Director of Molecular Biology at Geron Corporation
Committed to advancing science outside of bureaucratic bottlenecks
+ Many More
Revolutionary Sandbox Environment
Validated surrogate endpoints, accelerated FDA pathways, provisional Medicare reimbursement, and regulatory sandboxes designed for biotech. Custom frameworks by constitutional attorneys and federal policy experts—continuously optimized for founding tenants.
Leadership & Advisory Network
The experience behind Neovia.
Mark Hamilton
Founder
Economist, investor, renown author, and builder the word's #1 self-publishing empire. For over 45 years, Mark has developed alternative governance systems and advised global freedom movements, specializing in parallel frameworks that remove bureaucratic friction and unlock human progress. Today, he brings that expertise to the biomedical field—partnering with world-class scientists, companies, and policymakers to build deregulated innovation zones that fast-track breakthrough therapies and extend human life. With Neovia as the flagship, he is building a new class of parallel societies around the world, uniting elite thinkers, companies, and governments to pioneer a parallel system—one built for speed, freedom, and human flourishing.
Wallace Hamilton
Co-Founder
Entrepreneur, strategist, speaker, and a driving force behind Neovia—the launchpad for a new era of governance and innovation. Wallace co-develops next-tier regulatory and societal frameworks alongside Mark, designed to accelerate breakthroughs in biotech, AI, energy, and frontier technologies. As both visionary and builder, Wallace drives the execution—leading the ground-up buildout of systems, cities, alliances and structures that bring this new era to life, while rallying over 2,500 supporters behind the mission.
Art Finch
Founding Advisor
A leading expert on special economic zones and founder of the League of Free Cities—a global partnership and network that has collectively influenced most of the major special zone projects of the 21st century, advising on zones which have taken in over $5 billion in FDI worldwide. Art specializes in building high-trust relationships between governments and private industry to fast-track innovation. His expertise ensures Neovia delivers what top biotech companies care about most: speed, certainty, and infrastructure built for breakthrough science.
José Luis Cordeiro
Founding Advisor
Futurist, economist, and MIT-trained engineer. Founding faculty at Singularity University, fellow of the World Academy of Art & Science and co-author of The Death of Death, championing the end of aging through biotechnology. Director at The Millennium Project and founder of the International Longevity Summit, José advises governments, research institutions, and investors on breakthrough innovation and the future of human longevity. He has been Spanish candidate to the European Parliament.
Taavi Kotka & Team
Advsior
Architect of Estonia’s digital government and creator of the world’s first e-Residency program. As Estonia’s former CIO, his innovations in digital governance have been adopted globally and are now studied by leading institutions. At Neovia, Taavi and his famous team will lead the design of streamlined regulatory and compliance systems to support biotech innovation at scale.
Cody Dean
Ambassador
Entrepreneur and global ambassador for Neovia, Cody builds high-trust relationships with industry leaders, policymakers, and scientists to advance our mission. With deep roots in the longevity space and a proven ability to turn connections into strategic partnerships, he represents Neovia at key events and ensures the right stakeholders are aligned to move innovation forward.
Support Network
Aubrey De Grey, PHD
Founder & Chief Science Officer, LEV Foundation | Global Leader in Reversing Aging
Dr. Aubrey de Grey, often called the "godfather of longevity" is one of the world’s foremost voices in longevity science and biomedical aging reversal. As Founder and Chief Science Officer of the LEV Foundation, he leads cutting-edge research focused on repairing the molecular and cellular damage that drives aging and age-related diseases.
Trained at the University of Cambridge, where he earned a Ph.D. in biology and a BA in computer science, Dr. de Grey has dedicated his career to mapping every known hallmark of aging—and designing interventions to prevent or reverse them. He is a Fellow of both the Gerontological Society of America and the American Aging Association, and serves on the advisory boards of leading journals and biotech initiatives.
Known for his bold vision that aging is a disease we can—and must—cure, Dr. de Grey is a globally sought-after speaker and tireless advocate for life extension. His leadership has inspired an entire generation of longevity researchers, and his partnership with Neovia furthers our mission to end unnecessary death and suffering.
Prof. Dr. Mike Chan
Chairman, European Wellness Biomedical Group | Global Pioneer in Regenerative Medicine & Stem Cell Therapy
Prof. Dr. Mike Chan is a globally recognized pioneer in stem cell science, regenerative medicine, and biological anti-aging therapies. As the Co-Founder and Chairman of European Wellness Biomedical Group (Germany), he leads a multinational biotech empire spanning over 80 countries, with R&D, manufacturing, and over 40 medical wellness centers across Europe and Asia.
With over 40 years in the field, Dr. Chan has authored 60+ scientific books, published 100+ papers, and holds 40+ international patents in stem cell, peptide, immunology, and biopharmaceutical technologies. He was one of the first scientists to introduce stem cell therapy to Asia in the 1980s and has since educated thousands of physicians worldwide through over 1,000 global lectures and symposiums.
He serves on the boards of major international scientific bodies, including as Head of the Scientific Committee for ESAAM (Europe’s largest anti-aging medical association), and collaborates with elite institutions like MIT, Oxford, and Heidelberg University. Honored with more than 17 international awards and featured on 30+ magazine covers, Dr. Chan is a visionary leader accelerating the global future of regenerative medicine—and a proud founding supporter of Neovia.
Dr. Greg Fahy
Chief Scientific Officer, 21st Century Medicine | Pioneering Aging Reversal & Cryopreservation Expert
Dr. Greg Fahy is a world-renowned biogerontologist, cryobiologist, and longevity pioneer best known for leading the groundbreaking TRIIM trial—the first human study to demonstrate regeneration of the thymus and biological age reversal. He holds multiple patents related to thymus regeneration and has been a Fellow and longtime Director of the American Aging Association.
As Chief Scientific Officer of 21st Century Medicine, Dr. Fahy has led revolutionary advancements in organ cryopreservation, including the first successful transplantation of a kidney preserved at -130°C and the co-winning of both the Small and Large Mammal Brain Preservation Prizes.
A lifelong explorer of human longevity, Dr. Fahy edited The Future of Aging: Pathways to Human Life Extension, a foundational text in the field. His current research, based at Stanford University, focuses on reversing immune system aging—one of the leading causes of death in older adults. He brings to Neovia decades of visionary science and a bold mission: to make aging optional.
Elizabeth Parrish
Founder & CEO, BioViva Sciences | Pioneer of Gene Therapy & Human Longevity
Elizabeth Parrish is a globally recognized biotech innovator, humanitarian, and CEO of BioViva Sciences, a leading gene therapy company advancing the reversal of biological aging and age-related diseases. She is best known for becoming the first person in history to undergo experimental gene therapy to reverse aging, demonstrating her personal commitment to pushing the boundaries of science.
Liz leads BioViva's development of combinatorial gene therapies using its proprietary CMV delivery platform, with a mission to extend healthy human lifespan. She is also a vocal advocate for the Best Choice Medicine framework—a progressive regulatory model designed to accelerate access to transformative genetic treatments.
As a founding member of the International Longevity Alliance and affiliated with the Complex Biological Systems Alliance, Liz combines advocacy, investment, and science through initiatives like BioTrove Investments and the BioTrove Podcast. A frequent speaker at TEDx, WIRED, and major biotech forums, she is a leading voice in the movement to treat aging as a disease—and a visionary partner in the Neovia mission to save lives and shape the future of medicine.
Dr. Bill Andrews
Founder & CEO, Sierra Sciences | World Leader in Telomere Biology & Lifespan Extension
Dr. Bill Andrews is a pioneering molecular biologist, inventor, and longevity researcher best known for his groundbreaking work on telomeres—the protective caps on our chromosomes that act as a biological clock of aging. As Founder and CEO of Sierra Sciences, Dr. Andrews has spent decades developing therapeutic solutions to lengthen telomeres and extend human healthspan and lifespan.
In the 1990s, while at Geron Corporation, he led the team that discovered both the RNA and protein components of telomerase, the enzyme responsible for preventing telomere shortening—an achievement that reshaped the field of aging research. Today, his company continues to develop telomerase-based therapies aimed at reversing age-related decline in humans.
Dr. Andrews holds over 50 U.S. patents on telomerase and has been featured in Popular Science, The Today Show, and the award-winning documentary The Immortalists, which he co-starred in alongside Dr. Aubrey de Grey. A recipient of the National Inventor of the Year award (2nd place, 1997), he also holds a Ph.D. in Molecular and Population Genetics from the University of Georgia.
In addition to his scientific achievements, Dr. Andrews is a world-class ultramarathon runner, often competing in 100+ mile races in extreme environments. His personal quest to cure aging is both professional and personal—and his visionary partnership with Neovia reflects his belief that telomere shortening is the ultimate barrier to human longevity—and it can be overcome.
Dr. Jean Herbert
Neuroscientist & ARPA-H Program Manager | Pioneer in Brain Tissue Regeneration & Longevity Technologies
Dr. Jean Hébert is a leading neuroscientist, geneticist, and translational innovator focused on reversing brain aging and replacing damaged brain tissue to radically extend human cognitive health and lifespan. His career has been defined by a singular mission: to accelerate the use of cutting-edge technologies to replace, regenerate, and restore the human body—starting with the brain.
Dr. Hébert earned his Ph.D. in Genetics from UCSF, where he studied embryonic stem cell differentiation, followed by postdoctoral research at Stanford on how neural stem cells generate the neocortex—the seat of higher cognition. He later served as a Professor of Neuroscience and Genetics at Albert Einstein College of Medicine, leading a lab focused on reversing brain aging through tissue-based approaches.
To fast-track this vision to clinical reality, Dr. Hébert founded a biotech company developing functional neocortical tissue replacement and now serves as a Program Manager at ARPA-H, where he advances some of the U.S. government's most ambitious projects in brain regeneration and human longevity. He is a personal supporter of the Neovia mission to cure aging and expand the frontiers of human potential.
Bernard Siegel, JD
Executive Director, Regenerative Medicine Foundation | Global Advocate for Ethical Biotech & Patient-Centered Innovation
Bernard Siegel is a visionary attorney, advocate, and international leader in regenerative medicine policy and public engagement. As the Founder and Executive Director of the Regenerative Medicine Foundation and the Healthspan Action Coalition, he has spent over two decades building the global infrastructure for ethical, patient-driven advancement in stem cell and longevity science.
Best known for filing the landmark legal case that exposed the world’s first alleged human cloning hoax, Siegel pivoted from a 30-year legal career to become one of the most influential voices in biotech advocacy. He founded and co-chaired 20+ World Stem Cell Summits, initiated groundbreaking dialogues at the United Nations, and helped lead campaigns that protected critical research from global bans.
Siegel has advised, convened, and mobilized over 100 international organizations and served on high-impact boards such as Alliance for Regenerative Medicine, Coalition for the Advancement of Medical Research, and California’s Proposition 14 ($5.5B stem cell funding initiative). He has spoken at the Vatican, the White House, and the World Congress on Freedom of Scientific Research, and appeared on major media outlets including CNN, CBS, NPR, and Fox News.
A lifelong defender of scientific freedom and patient access, Siegel continues to shape global policy and collaboration around regenerative medicine—and stands as a powerful ally in the Neovia mission to accelerate cures and expand healthy human lifespan.
Ben Blue
CEO & Co-Founder, Ora Biomedical | AI-Powered Longevity Drug Discovery Pioneer
Ben Blue is the CEO and Co-Founder of Ora Biomedical, a next-generation biotech company using AI and robotics to rapidly discover small molecules that extend lifespan and prevent age-related decline. Developed out of the University of Washington, Ora’s proprietary WormBot platform allows for whole-organism drug screening at unprecedented speed—opening vast swaths of unexplored chemical space.
With a Ph.D. in biology focused on aging, Ben has devoted his career to translating cutting-edge science into accessible therapeutics. Under his leadership, Ora has developed molecules that protect human cells from radiation and aging damage—research supported by the U.S. Air Force and Space Force—and is advancing treatments for skin aging, cancer prevention, and immune resilience.
Ora acts as a crucial bridge to longevity escape velocity, offering therapies that work today while paving the way for future breakthroughs. Based in Seattle with in-house R&D labs and robotic platforms, Ora also supports preclinical screening for other biotech partners—delivering results in weeks, not years.
Ben joins Neovia as a strategic partner committed to accelerating cures through smarter systems, faster timelines, and a shared mission to make aging optional.
Bill Faloon
Co-Founder, Life Extension Foundation | Biomedical Visionary & Longevity Advocate
Bill Faloon is a pioneering voice in the fight against aging and one of the earliest champions of medical innovation to extend human lifespan. As Co-Founder of the Life Extension Foundation, he has spent over 40 years advancing access to cutting-edge therapies—from supplements and off-label drugs to experimental age-reversal treatments.
A prolific author and researcher, Bill has written extensively on anti-aging science, early-access medicine, and the urgent need to treat aging as a disease. He also co-founded Age Reversal Therapeutics and the Society for Age Reversal, helping to bridge the gap between scientific discovery and public access.
Fiercely critical of regulatory delays that cost lives, Bill has dedicated his life to accelerating biomedical breakthroughs and empowering people with the tools to live longer, healthier lives. His work aligns deeply with Neovia’s mission to end unnecessary suffering through faster, freer medical innovation.
+ many more
Thousands Are Backing The Future Of Biotech Freedom
From world-renowned scientists and biotech CEOs to investors, policy leaders, and everyday visionaries—over 2,000+ people from all walks of life are uniting behind Neovia & the Immortalis movement to accelerate life-saving innovation.
Copyrights 2025 | Neovia | Terms & Conditions